ERBB2 and neoplasm: Z-M ADCN can specifically bind to HER2 which overexpressed in various cancer cells and enter tumor cells by endocytosis, then MMAE can be released through the degradation of valine-citrulline (Val-Cit) dipeptide group due to the cathepsin B enzyme in cancer cells.